When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALNA - Allena Pharma advances with its early-stage study for ALLN-346 in hyperuricemia
Allena Pharmaceuticals Inc.
Allena Pharmaceuticals (ALNA-1.3%) has dosed the first patient in a Phase 1 trial of ALLN-346, for the treatment of hyperuricemia (elevated levels of uric acid in the blood) in patients with gout and advanced chronic kidney disease (CKD).
More news on: Allena Pharmaceuticals, Inc., Healthcare stocks news,